脳幹グリオーマ薬の世界市場:販売動向2018

【英語タイトル】Global Pontine Glioma Drug Sales Market Report 2018

QYResearchが出版した調査資料(QYR8055244)・商品コード:QYR8055244
・発行会社(調査会社):QYResearch
・発行日:2018年5月3日
・ページ数:107
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:Pharma & Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、脳幹グリオーマ薬の世界市場について調査・分析し、脳幹グリオーマ薬のメーカー別販売量、市場シェア分析、種類別販売分析(8H-9、A-10、AdRTSIL-12、アファチニブジマレート、AZD-1775、その他)、用途別販売分析(診療所、病院、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、脳幹グリオーマ薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・脳幹グリオーマ薬市場概要
・脳幹グリオーマ薬のメーカー別販売量・メーカー別シェア
・脳幹グリオーマ薬の世界市場:種類別販売量(8H-9、A-10、AdRTSIL-12、アファチニブジマレート、AZD-1775、その他)
・脳幹グリオーマ薬の世界市場:用途別販売量(診療所、病院、その他)
・脳幹グリオーマ薬の世界市場:地域別販売量・市場シェア
・脳幹グリオーマ薬の米国市場規模
・脳幹グリオーマ薬の中国市場規模
・脳幹グリオーマ薬の欧州市場規模
・脳幹グリオーマ薬の日本市場規模
・脳幹グリオーマ薬の東南アジア市場規模
・脳幹グリオーマ薬のインド市場規模
・脳幹グリオーマ薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・脳幹グリオーマ薬のコスト分析・価格動向
・脳幹グリオーマ薬の産業チェーン(サプライチェーン分析)
・脳幹グリオーマ薬のマーケティング戦略・販売チャネル、流通業者
・脳幹グリオーマ薬市場への影響要因分析
・脳幹グリオーマ薬の世界市場予測
・脳幹グリオーマ薬の米国市場予測
・脳幹グリオーマ薬の中国市場予測
・脳幹グリオーマ薬の欧州市場予測
・脳幹グリオーマ薬の日本市場予測
・脳幹グリオーマ薬の東南アジア市場予測
・脳幹グリオーマ薬のインド市場予測
・脳幹グリオーマ薬の種類別世界市場予測(8H-9、A-10、AdRTSIL-12、アファチニブジマレート、AZD-1775、その他)
・脳幹グリオーマ薬の用途別世界市場予測(診療所、病院、その他)
...
【レポートの概要】

This report studies the global Pontine Glioma Drug market status and forecast, categorizes the global Pontine Glioma Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
In 2017, the global Pontine Glioma Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major players covered in this report
Arog Pharmaceuticals, Inc.
Burzynski Research Institute, Inc.
Loxo Oncology, Inc.
Medicenna Therapeutics, Inc.
Medivation, Inc.
Novogen Limited
Sanofi

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

The regional scope of the study is as follows:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
8H-9
A-10
AdRTSIL-12
Afatinib Dimaleate
AZD-1775
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Clinic
Hospital
Others

The study objectives of this report are:
To analyze and study the global Pontine Glioma Drug sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Pontine Glioma Drug players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Pontine Glioma Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Pontine Glioma Drug Manufacturers
Pontine Glioma Drug Distributors/Traders/Wholesalers
Pontine Glioma Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Pontine Glioma Drug market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Pontine Glioma Drug Sales Market Report 2018
1 Pontine Glioma Drug Market Overview
1.1 Product Overview and Scope of Pontine Glioma Drug
1.2 Classification of Pontine Glioma Drug by Product Category
1.2.1 Global Pontine Glioma Drug Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Pontine Glioma Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 8H-9
1.2.4 A-10
1.2.5 AdRTSIL-12
1.2.6 Afatinib Dimaleate
1.2.7 AZD-1775
1.2.8 Others
1.3 Global Pontine Glioma Drug Market by Application/End Users
1.3.1 Global Pontine Glioma Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Pontine Glioma Drug Market by Region
1.4.1 Global Pontine Glioma Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Pontine Glioma Drug Status and Prospect (2013-2025)
1.4.3 Europe Pontine Glioma Drug Status and Prospect (2013-2025)
1.4.4 China Pontine Glioma Drug Status and Prospect (2013-2025)
1.4.5 Japan Pontine Glioma Drug Status and Prospect (2013-2025)
1.4.6 Southeast Asia Pontine Glioma Drug Status and Prospect (2013-2025)
1.4.7 India Pontine Glioma Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Pontine Glioma Drug (2013-2025)
1.5.1 Global Pontine Glioma Drug Sales and Growth Rate (2013-2025)
1.5.2 Global Pontine Glioma Drug Revenue and Growth Rate (2013-2025)

2 Global Pontine Glioma Drug Competition by Players/Suppliers, Type and Application
2.1 Global Pontine Glioma Drug Market Competition by Players/Suppliers
2.1.1 Global Pontine Glioma Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Pontine Glioma Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Pontine Glioma Drug (Volume and Value) by Type
2.2.1 Global Pontine Glioma Drug Sales and Market Share by Type (2013-2018)
2.2.2 Global Pontine Glioma Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Pontine Glioma Drug (Volume and Value) by Region
2.3.1 Global Pontine Glioma Drug Sales and Market Share by Region (2013-2018)
2.3.2 Global Pontine Glioma Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Pontine Glioma Drug (Volume) by Application

3 United States Pontine Glioma Drug (Volume, Value and Sales Price)
3.1 United States Pontine Glioma Drug Sales and Value (2013-2018)
3.1.1 United States Pontine Glioma Drug Sales and Growth Rate (2013-2018)
3.1.2 United States Pontine Glioma Drug Revenue and Growth Rate (2013-2018)
3.1.3 United States Pontine Glioma Drug Sales Price Trend (2013-2018)
3.2 United States Pontine Glioma Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Pontine Glioma Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Pontine Glioma Drug Sales Volume and Market Share by Application (2013-2018)

4 Europe Pontine Glioma Drug (Volume, Value and Sales Price)
4.1 Europe Pontine Glioma Drug Sales and Value (2013-2018)
4.1.1 Europe Pontine Glioma Drug Sales and Growth Rate (2013-2018)
4.1.2 Europe Pontine Glioma Drug Revenue and Growth Rate (2013-2018)
4.1.3 Europe Pontine Glioma Drug Sales Price Trend (2013-2018)
4.2 Europe Pontine Glioma Drug Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Pontine Glioma Drug Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Pontine Glioma Drug Sales Volume and Market Share by Application (2013-2018)

5 China Pontine Glioma Drug (Volume, Value and Sales Price)
5.1 China Pontine Glioma Drug Sales and Value (2013-2018)
5.1.1 China Pontine Glioma Drug Sales and Growth Rate (2013-2018)
5.1.2 China Pontine Glioma Drug Revenue and Growth Rate (2013-2018)
5.1.3 China Pontine Glioma Drug Sales Price Trend (2013-2018)
5.2 China Pontine Glioma Drug Sales Volume and Market Share by Players (2013-2018)
5.3 China Pontine Glioma Drug Sales Volume and Market Share by Type (2013-2018)
5.4 China Pontine Glioma Drug Sales Volume and Market Share by Application (2013-2018)

6 Japan Pontine Glioma Drug (Volume, Value and Sales Price)
6.1 Japan Pontine Glioma Drug Sales and Value (2013-2018)
6.1.1 Japan Pontine Glioma Drug Sales and Growth Rate (2013-2018)
6.1.2 Japan Pontine Glioma Drug Revenue and Growth Rate (2013-2018)
6.1.3 Japan Pontine Glioma Drug Sales Price Trend (2013-2018)
6.2 Japan Pontine Glioma Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Pontine Glioma Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Pontine Glioma Drug Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Pontine Glioma Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Pontine Glioma Drug Sales and Value (2013-2018)
7.1.1 Southeast Asia Pontine Glioma Drug Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Pontine Glioma Drug Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Pontine Glioma Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Pontine Glioma Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Pontine Glioma Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Pontine Glioma Drug Sales Volume and Market Share by Application (2013-2018)

8 India Pontine Glioma Drug (Volume, Value and Sales Price)
8.1 India Pontine Glioma Drug Sales and Value (2013-2018)
8.1.1 India Pontine Glioma Drug Sales and Growth Rate (2013-2018)
8.1.2 India Pontine Glioma Drug Revenue and Growth Rate (2013-2018)
8.1.3 India Pontine Glioma Drug Sales Price Trend (2013-2018)
8.2 India Pontine Glioma Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Pontine Glioma Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Pontine Glioma Drug Sales Volume and Market Share by Application (2013-2018)

9 Global Pontine Glioma Drug Players/Suppliers Profiles and Sales Data
9.1 Arog Pharmaceuticals, Inc.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Pontine Glioma Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Arog Pharmaceuticals, Inc. Pontine Glioma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Burzynski Research Institute, Inc.
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Pontine Glioma Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Burzynski Research Institute, Inc. Pontine Glioma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Loxo Oncology, Inc.
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Pontine Glioma Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Loxo Oncology, Inc. Pontine Glioma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Medicenna Therapeutics, Inc.
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Pontine Glioma Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Medicenna Therapeutics, Inc. Pontine Glioma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Medivation, Inc.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Pontine Glioma Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Medivation, Inc. Pontine Glioma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Novogen Limited
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Pontine Glioma Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Novogen Limited Pontine Glioma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Sanofi
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pontine Glioma Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Sanofi Pontine Glioma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview

10 Pontine Glioma Drug Maufacturing Cost Analysis
10.1 Pontine Glioma Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Pontine Glioma Drug
10.3 Manufacturing Process Analysis of Pontine Glioma Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Pontine Glioma Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Pontine Glioma Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Pontine Glioma Drug Market Forecast (2018-2025)
14.1 Global Pontine Glioma Drug Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Pontine Glioma Drug Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Pontine Glioma Drug Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Pontine Glioma Drug Price and Trend Forecast (2018-2025)
14.2 Global Pontine Glioma Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Pontine Glioma Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Pontine Glioma Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Pontine Glioma Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Pontine Glioma Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Pontine Glioma Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Pontine Glioma Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Pontine Glioma Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Pontine Glioma Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Pontine Glioma Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Pontine Glioma Drug Sales Forecast by Type (2018-2025)
14.3.2 Global Pontine Glioma Drug Revenue Forecast by Type (2018-2025)
14.3.3 Global Pontine Glioma Drug Price Forecast by Type (2018-2025)
14.4 Global Pontine Glioma Drug Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Pontine Glioma Drug
Figure Global Pontine Glioma Drug Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Pontine Glioma Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure 8H-9 Product Picture
Figure A-10 Product Picture
Figure AdRTSIL-12 Product Picture
Figure Afatinib Dimaleate Product Picture
Figure AZD-1775 Product Picture
Figure Others Product Picture
Figure Global Pontine Glioma Drug Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Pontine Glioma Drug by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Pontine Glioma Drug Market Size (Million USD) by Regions (2013-2025)
Figure United States Pontine Glioma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Pontine Glioma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Pontine Glioma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Pontine Glioma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Pontine Glioma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Pontine Glioma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Pontine Glioma Drug Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Pontine Glioma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Pontine Glioma Drug Sales Volume (K Pcs) (2013-2018)
Table Global Pontine Glioma Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Pontine Glioma Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Pontine Glioma Drug Sales Share by Players/Suppliers
Figure 2017 Pontine Glioma Drug Sales Share by Players/Suppliers
Figure Global Pontine Glioma Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Pontine Glioma Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Pontine Glioma Drug Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Pontine Glioma Drug Revenue Share by Players
Table 2017 Global Pontine Glioma Drug Revenue Share by Players
Table Global Pontine Glioma Drug Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Pontine Glioma Drug Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Pontine Glioma Drug by Type (2013-2018)
Figure Global Pontine Glioma Drug Sales Growth Rate by Type (2013-2018)
Table Global Pontine Glioma Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Pontine Glioma Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Pontine Glioma Drug by Type (2013-2018)
Figure Global Pontine Glioma Drug Revenue Growth Rate by Type (2013-2018)
Table Global Pontine Glioma Drug Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Pontine Glioma Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Pontine Glioma Drug by Region (2013-2018)
Figure Global Pontine Glioma Drug Sales Growth Rate by Region in 2017
Table Global Pontine Glioma Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Pontine Glioma Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Pontine Glioma Drug by Region (2013-2018)
Figure Global Pontine Glioma Drug Revenue Growth Rate by Region in 2017
Table Global Pontine Glioma Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Pontine Glioma Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Pontine Glioma Drug by Region (2013-2018)
Figure Global Pontine Glioma Drug Revenue Market Share by Region in 2017
Table Global Pontine Glioma Drug Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Pontine Glioma Drug Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Pontine Glioma Drug by Application (2013-2018)
Figure Global Pontine Glioma Drug Sales Market Share by Application (2013-2018)
Figure United States Pontine Glioma Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Pontine Glioma Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Pontine Glioma Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Pontine Glioma Drug Sales Volume (K Pcs) by Players (2013-2018)
Table United States Pontine Glioma Drug Sales Volume Market Share by Players (2013-2018)
Figure United States Pontine Glioma Drug Sales Volume Market Share by Players in 2017
Table United States Pontine Glioma Drug Sales Volume (K Pcs) by Type (2013-2018)
Table United States Pontine Glioma Drug Sales Volume Market Share by Type (2013-2018)
Figure United States Pontine Glioma Drug Sales Volume Market Share by Type in 2017
Table United States Pontine Glioma Drug Sales Volume (K Pcs) by Application (2013-2018)
Table United States Pontine Glioma Drug Sales Volume Market Share by Application (2013-2018)
Figure United States Pontine Glioma Drug Sales Volume Market Share by Application in 2017
Figure Europe Pontine Glioma Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Pontine Glioma Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Pontine Glioma Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Pontine Glioma Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Pontine Glioma Drug Sales Volume Market Share by Players (2013-2018)
Figure Europe Pontine Glioma Drug Sales Volume Market Share by Players in 2017
Table Europe Pontine Glioma Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Pontine Glioma Drug Sales Volume Market Share by Type (2013-2018)
Figure Europe Pontine Glioma Drug Sales Volume Market Share by Type in 2017
Table Europe Pontine Glioma Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Pontine Glioma Drug Sales Volume Market Share by Application (2013-2018)
Figure Europe Pontine Glioma Drug Sales Volume Market Share by Application in 2017
Figure China Pontine Glioma Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Pontine Glioma Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Pontine Glioma Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table China Pontine Glioma Drug Sales Volume (K Pcs) by Players (2013-2018)
Table China Pontine Glioma Drug Sales Volume Market Share by Players (2013-2018)
Figure China Pontine Glioma Drug Sales Volume Market Share by Players in 2017
Table China Pontine Glioma Drug Sales Volume (K Pcs) by Type (2013-2018)
Table China Pontine Glioma Drug Sales Volume Market Share by Type (2013-2018)
Figure China Pontine Glioma Drug Sales Volume Market Share by Type in 2017
Table China Pontine Glioma Drug Sales Volume (K Pcs) by Application (2013-2018)
Table China Pontine Glioma Drug Sales Volume Market Share by Application (2013-2018)
Figure China Pontine Glioma Drug Sales Volume Market Share by Application in 2017
Figure Japan Pontine Glioma Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Pontine Glioma Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Pontine Glioma Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Pontine Glioma Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Pontine Glioma Drug Sales Volume Market Share by Players (2013-2018)
Figure Japan Pontine Glioma Drug Sales Volume Market Share by Players in 2017
Table Japan Pontine Glioma Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Pontine Glioma Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Pontine Glioma Drug Sales Volume Market Share by Type in 2017
Table Japan Pontine Glioma Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Pontine Glioma Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Pontine Glioma Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Pontine Glioma Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Pontine Glioma Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Pontine Glioma Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Pontine Glioma Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Pontine Glioma Drug Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Pontine Glioma Drug Sales Volume Market Share by Players in 2017
Table Southeast Asia Pontine Glioma Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Pontine Glioma Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Pontine Glioma Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Pontine Glioma Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Pontine Glioma Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Pontine Glioma Drug Sales Volume Market Share by Application in 2017
Figure India Pontine Glioma Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Pontine Glioma Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Pontine Glioma Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table India Pontine Glioma Drug Sales Volume (K Pcs) by Players (2013-2018)
Table India Pontine Glioma Drug Sales Volume Market Share by Players (2013-2018)
Figure India Pontine Glioma Drug Sales Volume Market Share by Players in 2017
Table India Pontine Glioma Drug Sales Volume (K Pcs) by Type (2013-2018)
Table India Pontine Glioma Drug Sales Volume Market Share by Type (2013-2018)
Figure India Pontine Glioma Drug Sales Volume Market Share by Type in 2017
Table India Pontine Glioma Drug Sales Volume (K Pcs) by Application (2013-2018)
Table India Pontine Glioma Drug Sales Volume Market Share by Application (2013-2018)
Figure India Pontine Glioma Drug Sales Volume Market Share by Application in 2017
Table Arog Pharmaceuticals, Inc. Basic Information List
Table Arog Pharmaceuticals, Inc. Pontine Glioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Arog Pharmaceuticals, Inc. Pontine Glioma Drug Sales Growth Rate (2013-2018)
Figure Arog Pharmaceuticals, Inc. Pontine Glioma Drug Sales Global Market Share (2013-2018)
Figure Arog Pharmaceuticals, Inc. Pontine Glioma Drug Revenue Global Market Share (2013-2018)
Table Burzynski Research Institute, Inc. Basic Information List
Table Burzynski Research Institute, Inc. Pontine Glioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Burzynski Research Institute, Inc. Pontine Glioma Drug Sales Growth Rate (2013-2018)
Figure Burzynski Research Institute, Inc. Pontine Glioma Drug Sales Global Market Share (2013-2018)
Figure Burzynski Research Institute, Inc. Pontine Glioma Drug Revenue Global Market Share (2013-2018)
Table Loxo Oncology, Inc. Basic Information List
Table Loxo Oncology, Inc. Pontine Glioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Loxo Oncology, Inc. Pontine Glioma Drug Sales Growth Rate (2013-2018)
Figure Loxo Oncology, Inc. Pontine Glioma Drug Sales Global Market Share (2013-2018
Figure Loxo Oncology, Inc. Pontine Glioma Drug Revenue Global Market Share (2013-2018)
Table Medicenna Therapeutics, Inc. Basic Information List
Table Medicenna Therapeutics, Inc. Pontine Glioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Medicenna Therapeutics, Inc. Pontine Glioma Drug Sales Growth Rate (2013-2018)
Figure Medicenna Therapeutics, Inc. Pontine Glioma Drug Sales Global Market Share (2013-2018)
Figure Medicenna Therapeutics, Inc. Pontine Glioma Drug Revenue Global Market Share (2013-2018)
Table Medivation, Inc. Basic Information List
Table Medivation, Inc. Pontine Glioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Medivation, Inc. Pontine Glioma Drug Sales Growth Rate (2013-2018)
Figure Medivation, Inc. Pontine Glioma Drug Sales Global Market Share (2013-2018)
Figure Medivation, Inc. Pontine Glioma Drug Revenue Global Market Share (2013-2018)
Table Novogen Limited Basic Information List
Table Novogen Limited Pontine Glioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novogen Limited Pontine Glioma Drug Sales Growth Rate (2013-2018)
Figure Novogen Limited Pontine Glioma Drug Sales Global Market Share (2013-2018
Figure Novogen Limited Pontine Glioma Drug Revenue Global Market Share (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Pontine Glioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sanofi Pontine Glioma Drug Sales Growth Rate (2013-2018)
Figure Sanofi Pontine Glioma Drug Sales Global Market Share (2013-2018)
Figure Sanofi Pontine Glioma Drug Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pontine Glioma Drug
Figure Manufacturing Process Analysis of Pontine Glioma Drug
Figure Pontine Glioma Drug Industrial Chain Analysis
Table Raw Materials Sources of Pontine Glioma Drug Major Players in 2017
Table Major Buyers of Pontine Glioma Drug
Table Distributors/Traders List
Figure Global Pontine Glioma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Pontine Glioma Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Pontine Glioma Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Pontine Glioma Drug Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Pontine Glioma Drug Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Pontine Glioma Drug Sales Volume Market Share Forecast by Regions in 2025
Table Global Pontine Glioma Drug Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Pontine Glioma Drug Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Pontine Glioma Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Pontine Glioma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Pontine Glioma Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Pontine Glioma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Pontine Glioma Drug Revenue and Growth Rate Forecast (2018-2025)
Figure China Pontine Glioma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Pontine Glioma Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Pontine Glioma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Pontine Glioma Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Pontine Glioma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Pontine Glioma Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Pontine Glioma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Pontine Glioma Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Pontine Glioma Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Pontine Glioma Drug Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Pontine Glioma Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Pontine Glioma Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Pontine Glioma Drug Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Pontine Glioma Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Pontine Glioma Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

脳幹グリオーマ薬、8H-9、A-10、AdRTSIL-12、アファチニブジマレート、AZD-1775、診療所、病院

★調査レポート[脳幹グリオーマ薬の世界市場:販売動向2018] (コード:QYR8055244)販売に関する免責事項を必ずご確認ください。
★調査レポート[脳幹グリオーマ薬の世界市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆